Delivery Order SPE2DP23D0001-SPE2D625F9F4D
- Not listed
- The Defense Department's Medical Supply Chain division awarded a $2,090.49 firm fixed-price delivery order to Canadian Commercial Corporation (CCC) on May 20, 2025, with an ultimate completion date of August 5, 2025. This delivery order, contract number 4568321059, represents a child contract with no set-aside designation and will be performed in Ottawa, Ontario, Canada. CCC, a Crown corporation that serves as an intermediary facilitating government-to-government contracting between U.S. federal...
- The U.S. Defense Department's Medical Supply Chain division awarded a delivery order valued at $2,227.89 to Canadian Commercial Corporation (CCC) on July 25, 2025, for Reactive Skin Decontamination Lotion. This firm fixed-price contract, with an ultimate completion date of October 8, 2025, represents a child order under a larger indefinite delivery contract. The work will be performed at CCC's facility in Ottawa, Ontario, Canada. No set-aside designation was applied to this award, consistent...
- This is a $792,000.00 firm-fixed-price delivery order awarded by the Defense Logistics Agency Troop Support Medical to the Canadian Commercial Corporation (CCC), a Crown corporation owned by the Government of Canada that facilitates military exports and international contracting. The order is for Reactive Skin Decontamination Lotion, which CCC is providing as the prime contractor. CCC has subcontracted the manufacturing of the lotion to Emergent Biosolutions Canada Inc., a for-profit...
- The U.S. Department of Defense Medical Supply Chain awarded a delivery order to Canadian Commercial Corporation (CCC) on October 2, 2025, for the supply of Inactive Skin Decontamination Lotion 21. This contract, valued at $1,648.86, is a firm fixed-price delivery order with an ultimate completion date of December 18, 2025. The contract carries no set-aside designation, reflecting CCC's role as a Crown corporation facilitating government-to-government contracting between U.S. federal agencies and...
- The U.S. Department of Defense's Medical Supply Chain awarded a delivery order valued at $41,221.50 to Canadian Commercial Corporation (CCC) on October 2, 2025, for Inactive Skin Decontamination Lotion 21. This contract is a child delivery order under a larger indefinite delivery vehicle and utilizes firm fixed-price pricing with no set-aside designation. Performance will be completed by December 18, 2025, with work to be performed at CCC's facility in Ottawa, Ontario, Canada. The Reactive...
- This federal contract award, valued at $532,400.00, was issued by the Defense Logistics Agency Troop Support Medical to the prime contractor Canadian Commercial Corporation (CCC). CCC is a Crown corporation owned by the Government of Canada that facilitates military exports and international contracting opportunities for Canadian companies. The contract is for the delivery of Reactive Skin Decontamination Lotion (RSDL). CCC has subcontracted this work to Emergent Biosolutions Canada Inc., a...
- This is a delivery order awarded by the Defense Logistics Agency Troop Support Medical to the Canadian Commercial Corporation (CCC), a Crown corporation owned by the Government of Canada, for the provision of Reactive Skin Decontamination Lotion. The contract has a firm fixed price of $968,760.00 and a completion date of August 2, 2018. The place of performance is in Ottawa, Ontario, Canada. CCC is the prime contractor and has subcontracted with Emergent BioSolutions Canada Inc., a for-profit...
- The U.S. Department of Defense Medical Supply Chain awarded a delivery order to Canadian Commercial Corporation (CCC) on October 2, 2025, for Inactive Skin Decontamination Lotion 21. This contract, valued at $1,099.24 with a firm fixed price structure, represents a child delivery order with an ultimate completion date of December 18, 2025. The work will be performed at CCC's facility located in Ottawa, Ontario, Canada. No set-aside designation was utilized for this procurement, consistent with...
- This federal contract award, valued at $2,090.49, was issued by the U.S. Department of Defense to the Canadian Commercial Corporation (CCC), a Crown corporation owned by the Government of Canada. The contract is a Delivery Order for Firm Fixed Price items, with an ultimate completion date of September 18, 2025. CCC, which serves as a prime contractor to U.S. federal agencies, facilitates government-to-government contracting for Canadian exporters. The contract award does not utilize any...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Canadian Commercial Corporation, a Crown corporation owned by the Government of Canada, for $5,769,504.00. The order is for Reactive Skin Decontamination Lotion, which will be provided by Emergent Biosolutions Canada Inc. as a subcontractor to Canadian Commercial Corporation. No set-aside designation was used for this contract. Canadian Commercial Corporation often serves as a prime...
- SPE2DP23D0001Indefinite Delivery Contract
- SPE2DP23D0001-SPE2D625F9F4DDelivery Order
The U.S. Department of Defense, through its Medical Supply Chain office, awarded a $2,090.49 firm fixed-price delivery order to Canadian Commercial Corporation (CCC) on May 27, 2025, with an ultimate completion date of August 11, 2025. The contract calls for the delivery of Reactive Skin Decontamination Lotion, a critical medical countermeasure used by the military for protection against chemical, biological, radiological, and nuclear threats. CCC, a Canadian Crown corporation that specializes in facilitating government-to-government contracting between U.S. federal agencies and Canadian exporters, serves as the prime contractor with performance occurring at its facility in Ottawa, Ontario. This award does not utilize a set-aside designation, consistent with CCC's standard approach to federal contracting. CCC subcontracted the manufacturing of the Reactive Skin Decontamination Lotion to Emergent Biosolutions Canada Inc., a medical countermeasures provider with extensive experience supplying defensive medical supplies to U.S. government agencies. Emergent Biosolutions Canada has previously worked with CCC on similar deliveries and brings substantial expertise in producing therapeutics and vaccines against CBRN threats, having received over $770 million in federal contracts from agencies including the Defense Logistics Agency and the Department of Health and Human Services. The relatively modest ceiling value reflects a specific delivery order quantity, typical of task orders executed against larger indefinite delivery contracts or standing agreements that CCC maintains with defense logistics entities.
ContractNumber | Description | Subcontractor | Prime Award | Dollars Obligated | Updated At |
|---|---|---|---|---|---|
105929624S | None | Delivery Order SPE2DP23D0001-SPE2D625F9F4D | $2.1k | 5/28/25 | |
105929624S | Emergent Biosolutions Canada Inc. | Delivery Order SPE2DP23D0001-SPE2D625F9F4D | $0 | 5/28/25 |
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.1k | 5/27/25 |